ZBIO vs. HOOD

Last updated Aug 1, 2026

ZBIO (Zenas BioPharma, Inc) and HOOD (Robinhood Markets, Inc.) are both stocks. ZBIO operates in Biotechnology (Healthcare), while HOOD operates in Capital Markets (Financial Services). Over the past year, ZBIO returned 104.02% vs -13.35% for HOOD. Their 0.22 correlation means their historical movements had little consistent relationship.

Performance

ZBIO vs. HOOD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Zenas BioPharma, Inc (ZBIO) and Robinhood Markets, Inc. (HOOD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ZBIO achieves a -13.41% return, which is significantly higher than HOOD's -23.47% return.

ZBIO

• 1D: -2.57%
• 1M: 15.46%
• 6M: 71.15%
• YTD: -13.41%
• 1Y: 104.02%
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: 33.20%

HOOD

• 1D: -0.05%
• 1M: -23.21%
• 6M: -12.99%
• YTD: -23.47%
• 1Y: -13.35%
• 3Y*: 88.76%
• 5Y*: 19.75%
• 10Y*: —
• ALL TIME*: 17.88%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
HOOD Robinhood Markets, Inc.	$1.93B	$2.33B	$2.54B
ZBIO Zenas BioPharma, Inc	$26.67M	$25.00M	$19.37M

ZBIO vs. HOOD - Yearly Performance Comparison

	2026 (YTD)	2025	2024
ZBIO Zenas BioPharma, Inc	-13.41%	343.35%	-55.37%
HOOD Robinhood Markets, Inc.	-23.47%	203.54%	72.18%

Correlation

The correlation between ZBIO and HOOD is 0.19, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.19
Correlation (All Time) Calculated using the full available price history since Sep 13, 2024	0.22

Fundamentals

Market Cap ZBIO : $1.98B HOOD : $77.82B
EPS ZBIO : -$8.84 HOOD : $2.27
PS Ratio ZBIO : 151.20 HOOD : 23.99
PB Ratio ZBIO : 5.21 HOOD : 8.28
Total Revenue (TTM) ZBIO : $10.00M HOOD : $3.31B
Gross Profit (TTM) ZBIO : -$48.04M HOOD : $2.09B
EBITDA (TTM) ZBIO : -$255.29M HOOD : $2.44B

Return for Risk

ZBIO vs. HOOD — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ZBIO

ZBIO Risk / Return Rank: 74
ZBIO Sharpe Ratio Rank: 73
ZBIO Sortino Ratio Rank: 76
ZBIO Omega Ratio Rank: 80
ZBIO Calmar Ratio Rank: 74
ZBIO Martin Ratio Rank: 69

HOOD

HOOD Risk / Return Rank: 36
HOOD Sharpe Ratio Rank: 35
HOOD Sortino Ratio Rank: 37
HOOD Omega Ratio Rank: 36
HOOD Calmar Ratio Rank: 35
HOOD Martin Ratio Rank: 36

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ZBIO vs. HOOD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Zenas BioPharma, Inc (ZBIO) and Robinhood Markets, Inc. (HOOD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ZBIO	HOOD	Difference
Sharpe ratio: Return per unit of total volatility	0.91	-0.23	+1.14
Sortino ratio: Return per unit of downside risk	1.78	0.15	+1.64
Omega ratio: Gain probability vs. loss probability	1.27	1.02	+0.25
Calmar ratio: Return relative to maximum drawdown	1.55	-0.28	+1.83
Martin ratio: Return relative to average drawdown	2.68	-0.47	+3.16

ZBIO vs. HOOD - Sharpe Ratio Comparison

The current ZBIO Sharpe Ratio is 0.91, which is higher than the HOOD Sharpe Ratio of -0.23. The chart below compares the historical Sharpe Ratios of ZBIO and HOOD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ZBIO vs. HOOD - Drawdown Comparison

The maximum ZBIO drawdown since its inception was -74.96%, smaller than the maximum HOOD drawdown of -90.21%. Use the drawdown chart below to compare losses from any high point for ZBIO and HOOD.

Drawdown Indicators

	ZBIO	HOOD	Difference
Max Drawdown Largest peak-to-trough decline	-74.96%	-90.21%	+15.25%
Max Drawdown (1Y) Largest decline over 1 year	-64.79%	-57.26%	-7.53%
Max Drawdown (3Y) Largest decline over 3 years	—	-57.26%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-90.21%	—
Current Drawdown Current decline from peak	-27.17%	-43.22%	+16.05%
Average Drawdown Average peak-to-trough decline	-42.35%	-60.10%	+17.75%
Ulcer Index Depth and duration of drawdowns from previous peaks	37.47%	33.81%	+3.66%

Volatility

ZBIO vs. HOOD - Volatility Comparison

Zenas BioPharma, Inc (ZBIO) and Robinhood Markets, Inc. (HOOD) have volatilities of 16.84% and 17.67%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ZBIO	HOOD	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.84%	17.67%	-0.83%
Volatility (6M) Calculated over the trailing 6-month period	54.94%	53.55%	+1.39%
Volatility (1Y) Calculated over the trailing 1-year period	110.52%	70.22%	+40.30%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	106.47%	73.87%	+32.60%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	106.47%	73.91%	+32.56%

Dividends

ZBIO vs. HOOD - Dividend Comparison

Neither ZBIO nor HOOD has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ZBIO and HOOD in my portfolio?

ZBIO and HOOD have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ZBIO or HOOD?

HOOD has higher volatility (17.67%) compared to ZBIO (16.84%). In terms of maximum drawdown, ZBIO dropped -74.96% vs HOOD's -90.21%.

Which has better risk-adjusted returns?

ZBIO currently has the higher Sharpe Ratio (0.91 vs -0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.